Perrigo (PRGO) chairman and CEO Joseph Papa on Thursday leveled his harshest public criticism yet of Mylan’s hostile takeover effort, calling the company’s decision to lower the threshold for accepting Perrigo shares a “reckless action” and “sign of desperation” that ensured that Mylan’s promised cost savings of a combined company would fail.
Local generic drug giant Mylan (MYL) announced Thursday that it had loosened its terms for taking over Perrigo, lowering the number of shares it would take to seal the deal from 80 percent of Perrgio’s shares, down to greater than 50 percent.
“This scare tactic is simply an attempt to coerce Perrigo shareholders into a value destructive deal,” Mr. Papa said in a statement. “We don’t believe Perrigo shareholders will tender into this transaction at any threshold, and we are confident that there is no rational path to a full acquisition of Perrigo.”
Lowering the threshold would make Mylan’s consolidation with Perrigo, which specializes in over-the-counter medications, more lengthy and complicated, “taking a value destructive transaction and making it materially worse,” Mr. Papa said.
In two weeks, Mylan shareholders will vote at a special meeting in Amsterdam on whether to give management the OK to proceed with a tender offer for Perrigo shares. Mylan reincorporated in the Netherlands earlier this year in a controversial maneuver known as an inversion, but maintains its operations base in Cecil.
Assuming Mylan gets the go ahead — at least two leading proxy advisory firms are recommending approval — what’s the likelihood Mylan will ultimately win Perrigo?
Read More
Wall Street analyst Ronny Gal — who spoke with management of both firms on Monday — is putting the odds at less than 20 percent.
If Mylan shareholders OK the deal, “We suspect that Perrigo will present a series of value-enhancing steps to reinforce [Perrigo’s] value as an independent company,” Mr. Gal wrote in a note to clients this week.
He said he believed Mylan’s effort would fail because its cash and stock offer was too low, “especially if Perrigo conducts value enhancing steps,” and because the deal didn’t create enough value for Mylan shareholders.
Perrigo management has “high confidence” that Mylan will not convince more than 50 percent of Perrigo shareholders to tender their shares, Mr. Gal wrote, even though managers acknowledged that some of Perrigo’s large shareholders were “holding their cards close to their vest.”
For its part, Mylan on Thursday said it remained committed to capturing Perrigo.
“We intend to launch our offer to acquire Perrigo’s ordinary shares after we receive the approval of our shareholders,” executive chairman Robert Coury said in a statement.
“We look forward to making this combination a reality in the coming months.”
Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.